Notice for vedolizumab (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
vedolizumab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
For the treatment of pouchitis
Therapeutic area
Gastroenterology